<DOC>
	<DOCNO>NCT00131027</DOCNO>
	<brief_summary>The purpose study investigate clinical efficacy high-dose methotrexate consolidation therapy adult patient BCR-ABL-negative ALL .</brief_summary>
	<brief_title>High-Dose Methotrexate ( MTX ) Adult Acute Lymphoblastic Leukemia ( ALL )</brief_title>
	<detailed_description>Although multi-agent chemotherapy current use produce complete remission majority patient acute lymphoblastic leukemia ( ALL ) , prognosis adult ALL remain discourage due high incidence relapse . Optimal post-remission therapy , therefore , matter vital concern . In pediatric ALL study , use high-dose methotrexate ( MTX ) consolidation therapy , show improve outcome , however , randomize control trial test clinical efficacy adult ALL . With concern , Japan Adult Leukemia Study Group ( JALSG ) plan prospective randomized control trial compare high-dose MTX intermediate-dose MTX ALL patient negative BCR-ABL . Those positive BCR-ABL participate separate protocol .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Previously untreated BCRABLnegative ALL Age 25 64 year Performance status 0 3 ( ECOG criterion ) Adequate function liver ( serum bilirubin level &lt; 2.0 mg/dL ) ; kidney ( serum creatinine level &lt; 2.0 mg/dL ) ; heart ( leave ventricular ejection fraction great 50 % severe abnormality detect electrocardiograms echocardiograph ) . Written inform consent participate trial Uncontrolled active infection Another severe and/or lifethreatening disease Positive HIV antibody and/or hepatitis B surface ( HBs ) antigen test Another primary malignancy clinically active and/or require medical intervention Pregnant and/or lactate woman Past history renal failure</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>acute lymphoblastic leukemia</keyword>
	<keyword>newly diagnose</keyword>
	<keyword>BCR-ABL-negative</keyword>
</DOC>